FDA: Class I recall of SOLOPATH Balloon Expandable TransFemoral System, Re-Collapsible Balloon Access System
Editor's Note The Food & Drug Administration on May 30 identified the recall by Terumo Medical Corporation (Somerset, New Jersey) of its SOLOPATH Balloon Expandable TransFemoral System and Re-Collapsible Balloon Access System as Class I, the most serious. The recall was initiated because the tip could dislodge from the outer…
Association of step volume, intensity with mortality in older women
Editor's Note In this study, women who averaged approximately 4,400 steps per day had significantly lower mortality rates than women who took approximately 2,700 steps per day. Of 16,741 women with a mean age of 72 years analyzed, their mean step count was 5,499 per day.ย A step volume of approximately…
Joint Commission announces performance measures for heart attack certifications
Editor's Note The Joint Commission on May 29 announced performance measures for two newly developed advanced Disease-Specific Care Certification programsโAcute Heart Attack Ready and Primary Heart Attack Center. The measures will go into effect July 1, 2019, for critical access hospitals and hospitals (including freestanding emergency departments) pursuing these certifications.…
Survey: C-suite support needed to fully unleash nursing innovation
Editor's Note A new survey by the University of Pennsylvania School of Nursing and BDO Center for Healthcare Excellence & Innovation finds that clinical and business leaders value the innovation nurses bring to their organizations, just not at the C-suite level. Clinical and business leaders ranked skills, such as โthe…
FDA: Heritage Pharmaceuticals recalls Amikacin Sufate Injection, Prochlorperazine Edisylate Injection
Editor's Note The Food & Drug Administration (FDA) on May 28 announced the recall by Heritage Pharmaceuticals Inc (East Brunswick, New Jersey) of Amikacin Sulfate Injection, USP 1 gm/4 mL (250 mg/mL), Lot: VEAC025, Expiry Date: October 2019; and Prochlorperazine Edisylate Injection, USP 10 mg/2 mL (5 mg/mL), Lot: VPCA172,…
Association between postop delirium, cognitive dysfunction
Editor's Note In this study, postoperative delirium significantly increased the risk of postoperative cognitive dysfunction in older adults at 1 month after surgery, but there was no association at 2 and 6 months. Of 560 patients analyzed, 24% developed delirium during hospitalization. At 1 month after surgery, 47% had not…
NIH, radiology societies map path for AI research in medical imaging
Editor's Note A new report from the National Institutes of Health, Radiological Society of North America, American College of Radiology, and The Academy, provides a roadmap for translational research on artificial intelligence (AI) in medical imaging. The report summarizes key priorities: creating structured AI use cases that define and highlight…
Download ASC Manager
Weโre excited to introduce our first quarterly issue of ASC Manager! This is a time of great opportunity for Ambulatory Surgery Centers (ASCs) as the market is expected to grow significantly in the near future. ASC Manager offers you a roadmap for evaluating expansion opportunities, managing your growth, and producing…
Risks, benefits of using CHG for handwashing
Editor's Note Because of the potential risk of selecting mutants carrying genes for cross-resistance to chlorhexidine gluconate (CHG) and antibiotics, it is advisable to reserve the use of CHG for purposes other than hand hygiene, this study finds. A review of studies showed no significant difference in healthcare-associated infection rates…
FDA: Class I recall of Integra LifeSciences CSF drainage, ICP monitoring systems
Editor's Note The Food & Drug Administration on May 24 identified the recall by Integra LifeSciences of its LimiTorr Volume Limiting Cerebrospinal Fluid (CSF) Drainage System and the MoniTorr Intracranial Pressure (ICP) External CSF Drainage and Monitoring System as Class I, the most serious. The recall was initiated because of…